1. Home
  2. NKTR vs FVCB Comparison

NKTR vs FVCB Comparison

Compare NKTR & FVCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • FVCB
  • Stock Information
  • Founded
  • NKTR 1990
  • FVCB 2007
  • Country
  • NKTR United States
  • FVCB United States
  • Employees
  • NKTR N/A
  • FVCB 116
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • FVCB Major Banks
  • Sector
  • NKTR Health Care
  • FVCB Finance
  • Exchange
  • NKTR Nasdaq
  • FVCB Nasdaq
  • Market Cap
  • NKTR 200.6M
  • FVCB 206.6M
  • IPO Year
  • NKTR 1994
  • FVCB N/A
  • Fundamental
  • Price
  • NKTR $1.12
  • FVCB $11.36
  • Analyst Decision
  • NKTR Hold
  • FVCB
  • Analyst Count
  • NKTR 3
  • FVCB 0
  • Target Price
  • NKTR $1.00
  • FVCB N/A
  • AVG Volume (30 Days)
  • NKTR 882.7K
  • FVCB 26.8K
  • Earning Date
  • NKTR 11-05-2024
  • FVCB 10-22-2024
  • Dividend Yield
  • NKTR N/A
  • FVCB N/A
  • EPS Growth
  • NKTR N/A
  • FVCB N/A
  • EPS
  • NKTR N/A
  • FVCB 0.24
  • Revenue
  • NKTR $93,157,000.00
  • FVCB $44,610,000.00
  • Revenue This Year
  • NKTR N/A
  • FVCB N/A
  • Revenue Next Year
  • NKTR N/A
  • FVCB $14.84
  • P/E Ratio
  • NKTR N/A
  • FVCB $47.06
  • Revenue Growth
  • NKTR 6.17
  • FVCB N/A
  • 52 Week Low
  • NKTR $0.41
  • FVCB $9.78
  • 52 Week High
  • NKTR $1.93
  • FVCB $15.39
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 38.78
  • FVCB 47.49
  • Support Level
  • NKTR $1.19
  • FVCB $11.30
  • Resistance Level
  • NKTR $1.35
  • FVCB $12.78
  • Average True Range (ATR)
  • NKTR 0.10
  • FVCB 0.42
  • MACD
  • NKTR -0.01
  • FVCB -0.03
  • Stochastic Oscillator
  • NKTR 13.33
  • FVCB 29.52

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About FVCB FVCBankcorp Inc.

FVCBankcorp Inc is a registered bank holding company. It operates through the sole subsidiary, FVCbank which is a community-oriented, locally-owned, and managed commercial bank. It offers commercial banking services to small and medium-sized businesses, professionals, non-profit organizations and associations, and investors. It also provides retail banking services to accommodate the individual needs of both corporate customers as well as the communities it serves. The bank provides other facilities such as online banking, mobile banking, remote deposit service, and lending products, among others. Its primary source of revenue is the net interest income.

Share on Social Networks: